Picture of Reviva Pharmaceuticals Holdings logo

RVPH — Reviva Pharmaceuticals Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Reviva Pharma's schizophrenia drug succeeds in late-stage study

Oct 30 (Reuters) - Reviva Pharmaceuticals Holdings
 RVPH.O  said on Monday its experimental drug to treat adults
with schizophrenia met the main goal of a late-stage study.

 (Reporting by Mariam Sunny in Bengaluru; Editing by Savio
D'Souza)
 ((Mariam.ESunny@thomsonreuters.com;))

Recent news on Reviva Pharmaceuticals Holdings

See all news